Importantly, some studies indicate that ABCG2 sequence variants may be involved in modulating colorectal cancer risk, as the expression and activity of the transporter in the bowels can differ between individuals, due at least in part to genetic polymorphisms of the ABCG2 gene. This evidence concerns the gene ABCG2 and colorectal cancer.